ABSTRACT. To explore the possible association of hyperlipidemia with hyperammonemia and aspirin ingestion, the effects of NH4+, salicylate, and carnitine on the oxidation of [l-'4C]palmitic acid to acid-soluble products (ASP) and to C 0 2 were investigated in rat liver slices. DL-carnitine (5 mM) increased total oxidation (ASP + C02) more than oxidation to C02. KCN (1.5 mM) inhibited more than 90% of the oxidation. N&CI inhibited the oxidation that reached a maximum at about 40 mM, but the inhibition of oxidation to COz (63%) was larger than that of total oxidation (30%). Carnitine did not influence NH4+ inhibition, which is consistent with the results reported for isolated mitochondria. Salicylate effects depended on salicylate concentration as well as on the presence of carnitine. In the absence of carnitine, inhibition of total oxidation reached 90% at 3 mM salicylate but that of oxidation to C 0 2 reached 50%. Velocity calculated at saturating palmitic acid concentration for total oxidation was slightly increased by 0.75 mM salicylate, but the increase for oxidation to C 0 2 was larger. At 3 mM salicylate, velocity at saturating palmitic acid concentration for the oxidation was decreased, but the decrease for oxidation to COz was smaller than for total oxidation. Carnitine partially relieved the inhibition of total oxidation and further increased the formation of COz. The combination of 20 mM NKCI and 0.75 rnM salicylate inhibited total oxidation, which was more than additive of the individual effects, and carnitine partially relieved the inhibition. It is concluded that NH4+ exerted a stronger inhibition of oxidation to COZ than of oxidation to ASP, whereas salicylate strongly inhibited the oxidation to ASP but increased the oxidation to COz by uncoupling mitochondrial oxidative phosphorylation. Therefore, hyperammonemia and aspirin ingestion can inhibit fatty acid oxidation and mitochondrial metabolism that could lead to the pathophysiology seen in some childhood diseases such as Reye's syndrome. Carnitine therapy might offer some benefits. (Pediatr Res 25:119-123,1989 Abbreviations RS, Reye's syndrome ASP, acid soluble products V,, velocity calculated for saturating substrate (palmitic acid) concentration Elevation of serum-free fatty acids and fatty infiltration of liver are some of the common pathologic manifestations in children with enzyme defects of the urea cycle (1) and RS (2). Hyperammonemia is also an early laboratory finding in these disease states. It is suggested that the pathophysiology of RS is a metabolic response to an acute injury to mitochondria (3). Among many factors, salicylate, which is the predominant product circulating in blood after ingestion of aspirin, has been implicated in the etiology of RS (4). Salicylate may interfere with the synthesis of high energy phosphates and contribute to mitochondrial degeneration because salicylate uncouples mitochondrial respiration (5), inhibits the activation of fatty acids (6) and induces mitochondrial swelling (7). Similar damaging effects on mitochondria were observed with the serum of RS patients (8, 9). In animal model studies of RS, feeding an arginine-deficient diet produced hyperammonemia followed by hyperlipidemia (LO). The possible association between hyperammonemia and hyperlipidemia became more apparent when NH4+ was found to inhibit the oxidation of fatty acids but not of succinate or malate + glutamate in isolated rat liver mitochondria (1 1).
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Elevation of serum-free fatty acids and fatty infiltration of liver are some of the common pathologic manifestations in children with enzyme defects of the urea cycle (1) and RS (2) . Hyperammonemia is also an early laboratory finding in these disease states. It is suggested that the pathophysiology of RS is a metabolic response to an acute injury to mitochondria (3). Among many factors, salicylate, which is the predominant product circulating in blood after ingestion of aspirin, has been implicated in the etiology of RS (4) . Salicylate may interfere with the synthesis of high energy phosphates and contribute to mitochondrial degeneration because salicylate uncouples mitochondrial respiration (5), inhibits the activation of fatty acids (6) and induces mitochondrial swelling (7) . Similar damaging effects on mitochondria were observed with the serum of RS patients (8, 9) . In animal model studies of RS, feeding an arginine-deficient diet produced hyperammonemia followed by hyperlipidemia (LO). The possible association between hyperammonemia and hyperlipidemia became more apparent when NH4+ was found to inhibit the oxidation of fatty acids but not of succinate or malate + glutamate in isolated rat liver mitochondria (1 1).
The oxidation of fatty acids in liver is important not only for the energy metabolism but also for the clearance of triglycerides and free fatty acids (12) . Medium-chain fatty acids are oxidized mostly in mitochondria, whereas long-chain fatty acids are also oxidized in peroxisomes (I 3). Carnitine is known to function in the transport of medium-and long-chain fatty acids in to mitochondria (14) as well as in some other metabolic processes (15) . In view of these findings and that of increased lipolysis after an enhanced release of catecholamines in RS patients (12) , a study of the effects of salicylate and NH4+ on the oxidation of [I-I4C] paImitic acid to ASP and C02 was undertaken in liver slices with and without added carnitine. The results showed that both agents inhibited the oxidation by different degrees, and salicylate inhibition was partially relieved by carnitine.
MATERIALS AND METHODS
Male Sprague-Dawley rats (250-350 g) were raised in house and maintained on Purina Laboratory Rat Chow (Ralston-Purina, St. Louis, MO) ad libitum. Rats were killed by stunning, followed by decapitation. Livers were quickly removed and placed into ice-cold Ca2+ free Krebs-Ringer phosphate buffer (1 19 mM NaCl, 4.7 mM KCI, 6 mM MgS04-7H20, and 15.5 mM phosphate buffer, pH 7.4). Liver was cut into 1 cm2 pieces, washed. and sliced in a Stadie-Rims microtome (Thomas Scientific, ~wedesboro, NJ) kept cold% ice. Slices 0.i-to 0.2-mm thick were blotted and weighed. Approximately 250 mg of liv-adjusted to pH 7.4. After all the additions, including [l-I4C] palmitic acid, were made, the flasks were sealed with rubber stoppers fitted with center well cups containing 0.3 ml of 10% KOH. The reaction flasks, in duplicate, were incubated in a shaking water bath for 60 min at 37°C. The reaction was stopped by adding 0.4 ml of 5 N perchloric acid and incubated for an additional 45 min to trap all the C02. Perchloric acid was added before slices in 0 time controls. The reaction mixture was centrifuged, and radioactivity in the supernatant and of the center well cup was measured separately in a liquid scintillation counter (LS-133, Beckman Instruments Inc., Fullerton, CA). After 0 time blank values were subtracted, radioactivity in ASP and CO2 varied from 500-2000 and from 10,000-75,000 cpm, respectively, depending on the concentration of palmitic acid, carnitine, and modifiers. Rate of oxidation was expressed as nmol of palmitic acid oxidized/h/g wt liver. The rate was linear up to 60 min and was proportional to tissue up to 1 g. All chemicals, except BSA fraction V (United States Biochemical Corporation, Cleveland, OH), were of reagent grade and purchased from Sigma Chemical Co. (St. Louis, MO). [l-14C]palmitic acid (58 mCi/ mmol) was purchased from DuPont NEN (Wilmington, DE).
RESULTS
The oxidation of fatty acids in mitochondria generates acetylCoA which is generally channeled toward ketone body formation and tricarboxylic acid cycle for oxidation to C02 and HzO. The completion of the first cycle of P-oxidation pathway by [l-I4C] palmitic acid would yield radioactive acetyl-CoA and its metabolites (ketones, tricarboxylic acid cycle intermediates, and possibly some amino acids) (16) which are acid soluble (Fig. I ). Recent studies (16, 17) have indicated that the use of [l-I4C] palmitic acid along with the determination of radioactivity in C02 as well as in ASP was adequate for an evaluation of fatty acid oxidation in complete tissue preparations. The sum of radioactivity in ASP and C02, which is presented as total oxidation, would be a measure of the oxidation of palmitic acid to acetyl-CoA, whereas that of C02 would be a measure of the oxidation of acetyl-CoA in the tricarboxylic acid cycle (Fig. 1 ). The addition of increasing concentrations of palmitic acid to the incubation medium increased the oxidation to ASP and CO2 (Fig. 2) . The rate of oxidation increased with the concentration of DL-carnitine and plateaued at 2-3 mM (not shown). In a patient with methylmalonic aciduria, DL-carnitine was found to be effective in increasing urinary excretion of acylcarnitines but decreasing the excretion of methylmalonate and methylcitrate (18) . Although the D-isomer of carnitine is physiologically inactive, it does not appear to affect the transport or other functions of the L-isomer (19) . Because whole liver was the tissue of study, 5 mM ~L-carnitine was routinely included where indicated. The effective concentration of L-carnitine in the incubation medium would be 2.5 mM. Kinetic analysis of these and other data is presented in a later section. Carnitine caused a larger increase in the oxidation to ASP + C 0 2 than to COz because it decreased the percentage contribution of COz to total oxidation from 4.4 + 0.9 to 1:7 a 0.8 @ c 0.001, by Student's t test). The latter value agrees with that reported for liver homogenate from fed rats (1 6) . Because CO2 formation is only a small fraction of ASP + CO2, especially in the presence of carnitine, total oxidation may virtually represent oxidation of palmitic acid to ASP.
Effecls of NH4Cl and salicylale on oxidation. The concentration of total fatty acids in the serum drawn early in morning from healthy children was found to be 40-60 pM (20) . Therefore, rates of oxidation were measured at a fixed concentration of 40 FM palmitic acid with varying concentrations of NH4Cl and salicylate in the absence and presence of 5 mM DL-carnitine. NH4Cl inhibited total oxidation as well as formation of COz but the inhibition of the latter was greater (Fig. 3) . The inhibition plateaued at about 30% for total oxidation and at about 63% for COZ formation (40 mM NH4CI). Consequently, NH4CI decreased (2) CoASH, (3) palmitoyl-CoA, (4) palmitoylcarnitine, (5) myristoyl-CoA, and (6) acetyl-CoA. the percent contribution of C02 to total oxidation. The addition of carnitine increased the rate of total oxidation but did not alter the extent of inhibition (Fig. 3) .
Effects of varying the concentration of salicylate are shown in Figure 4 . The effects on total oxidation and COz formation were different and were further modified by carnitine. In the absence of carnitine, steep inhibition of total oxidation occurred which plateaued to about 90% at 3 mM salicylate (Fig. 4) . However, oxidation to COz was slightly increased at low concentrations of salicylate (< 0.5 mM), beyond which inhibition occurred plateauing to about 55% at 3 mM. In the presence of carnitine, modifying effects depended on the concentration of salicylate (Fig. 4) . Up to 0.75 mM salicylate level, total oxidation was either slightly increased or unchanged, but beyond that level, inhibition occurred and increased gradually reaching about 55% at 3.0 mM. The activating effects of low salicylate concentrations and carnitine were most pronounced for COz formation than for total oxidation (Fig. 4) . For example, the activation of oxidation to COz peaked (180%) at 0.75 mM salicylate and gradually declined to the 100% level at 3.0 mM. Even 5.0 mM salicylate did not significantly inhibit the CO2 formation.
Effects of KCN on oxidation. Peroxisomal contribution to palmitic acid oxidation in liver slices was evaluated by using KCN (1.5 mM) as an inhibitor of mitochondrial activity (21) in the absence and presence of modifiers. KCN inhibited total oxidation by 92 and 95% in the presence and absence of carnitine, respectively ( Table 1) . Formation of COz was almost completely inhibited (not shown). Although the percentage inhibition by KCN was variable in the presence of NH4CI, salicylate, and carnitine, the rate of total oxidation remained constant at a low * incubations were carried out as described in "Materials and Methods," and the concentration of added cold palmitic acid was 80 (palmitic acid:albumin, 5:l). R~t e of oxidation is shown as nmol of palmitic acid/h/g wet liver at 37°C and is an average of two different experiments with duplicate incubations. level (2-3 nmol) that may represent the oxidative activity of peroxisomes under the present experimental conditions.
Efects of modifiers on kinetics. The rate of oxidation increased
with the increasing concentration of palmitic acid and tended to follow saturation kinetics (Fig. 2) . The addition of modifiers (NH4Cl and salicylate) did not alter the rate dependence on the concentration but caused inhibition, and the magnitude of their effects were different (not shown). A kinetic analysis was canied out by fitting the data to Lineweaver-Burke equation (22) using the software program ENZPACK (written by PA Williams, Elsevier-BIOSTAT, Cambridge, United Kingdom). The correlation coefficient for a linear fit to the Lineweaver-Burke plot varied from 0.9 to 1. Although many enzymatic steps are involved in the oxidation of palmitic acid (Fig. l) , calculation of V, should 122 MADDAIAH AND MILLER prove useful for the purpose of comparison of the effects of different modifiers. Effects of NH4C1, salicylate, and carnitine on V, are shown in Table 2 . Carnitine increased the oxidative utilization from an average of 15% to 35% of the added palmitic acid (Fig. 2) , and V, for total oxidation was increased Cfold, whereas the formation of CO2 was only slightly increased.
The addition of NH4CI (20 mM) decreased the V, of total oxidation and of C02 formation, but the inhibition of the latter (56%) was larger than that of total oxidation (17%). Carnitine did not alter the pattern of inhibition, but the magnitude of inhibition of oxidation to C02 was increased to more than 90% whereas the inhibition of total oxidation was slightly increased (27%). These results confirm the relatively larger inhibition of oxidation to C02 than to total products by NH4+, as shown in Figure 2 .
As shown previously, the modifying effects of salicylate depended on its concentration (Fig. 4) . Therefore, kinetic experiments were carried out at low (0.75 mM) and high (3.0 mM) concentrations. In the absence of carnitine, the addition of 0.75 mM salicylate generally increased the rates (Table 2) . However, V, for oxidation to COz was increased by 240%, whereas that of total oxidation was increased by only 163%. The addition of carnitine along with salicylate increased the V, for oxidation to CO2 by 170% over that of carnitine alone, but the V, for total oxidation was only slightly increased (1 18%). These results suggest that the maximum capacity for total oxidation was attained in the presence of carnitine alone, whereas that for oxidation to C 0 2 was attained in the presence of salicylate. At the high salicylate concentration (3.0 mM), V, was decreased by 47 and 92% for CO2 formation and total oxidation, respectively. In the additional presence of carnitine, the V, for C02 formation was increased by more than 230% and the V, for total oxidation was decreased by 72% when compared to the presence of carnitine alone. Carnitine has, therefore, altered the modifying action of 3.0 mM salicylate on oxidation to COz from inhibition to activation. These results are in agreement with those observed at varying concentrations of NH4CI and salicylate as presented in Figures 3 and 4 .
Whether there was any interaction between the modifiers was examined by measuring the kinetics of oxidation in the presence of 20 mM NH4CI and 0.75 mM salicylate ( Table 2 ). The combined presence did not change V, for CO2 formation. The inhibitory (NH4Cl) and activating (salicylate) effects may have balanced out in maintaining the V, unchanged. However, the com- bined effect on total oxidation (Table 2 ) was more than the sum of the individual effects on V, because the rate was decreased by 50 and 60% in the absence and presence of carnitine, respectively.
DISCUSSION
Identification of the mitochondrion as the site of palmitic acid oxidation is important because previous studies with NH4+ (1 1) and salicylate (5-9) were done with isolated mitochondria. Strong inhibition of oxidation by KCN and the absence of carnitine effect on it suggested that palmitic acid was almost exclusively oxidized in mitochondria. Depression of peroxisomal oxidation by KCN consequent to decreased ATP synthesis cannot be completely excluded. However, production of very low ievels of H202 when livers were perfused with palmitic acid indicated that peroxisomal oxidation was negligible (23) . Studies of liver homogenates using a variety of inhibitors of mitochondria1 oxidation suggested that peroxisomal contribution was less than 10% (24) . Therefore, the observed effects of the modifiers may entirely be due to their actions on mitochondria.
The rates of palmitic acid oxidation and the percentage contribution of CO2 to total oxidation were generally low because the livers were from fed rats (1 6). Although, the rate of oxidation in liver slices from 24-h fasted rats was higher than those presented here, the effects of NH4CI and salicylate (Maddaiah VT, and Miller PS, unpublished results) were similar. The large and similar activating effect of 5 mM carnitine on the oxidation of palmitic acid to ASP + CO2 was not reflected in a similar increase of oxidation to C02 in the tricarboxylic acid cycle. The absence of a direct relationship between the oxidation of palmitic acid to acetyl-CoA and to CO2 has been demonstrated in hepatocytes (25) by the use of inhibitors of carnitine-dependent oxidation.
About 60% of the O2 consumed by hepatocytes during palmitic acid oxidation was found to be associated with acetyl-CoA formation, and the remainder was assumed to represent the oxidation of acetyl-CoA to CO2 and Hz0 in the tricarboxylic acid cycle (25) . On the basis of this and the present finding that NH4' inhibited palmitic acid oxidation to acetyl-CoA, as represented by ASP + CO2, and to COr by 30 and 60%, respectively, it is possible to calculate the extent of NH4+ inhibition of 0 2 consumption during palmitic acid oxidation to be about 40%. Indeed, NH4+ (2 mM) inhibited 0 2 consumption (state 3 respiration) by rat liver mitochondria respiring on palmitoyl-L-carnitine or octanoic acid by 40% (1 I). The higher concentration of NHdC1 required to exert maximum inhibition in liver slices may be due to low permeability and high metabolism of NH4' . The absence of carnitine influence on inhibition of oxidation to acetyl-CoA supports the previous conclusion (1 1) that inhibition occurred at step(s) beyond fatty acid transport into mitochondria. The larger inhibition of C02 formation when compared to ASP + C02 suggests at least two sites of NH4' inhibition in the pathway of palmitic acid oxidation to C02. One of the sites is in the Poxidation pathway (Fig. 5) . Because NH4+ inhibited the oxidation of palmitoyl-L-carnitine but not of succinate or malate + glutamate in liver mitochondria (1 l), respiratory chain as a site of inhibition may be excluded. Therefore, the other inhibitory site may lie in the pathway of utilization of acetyl-CoA in the tricarboxylic acid cycle. A slight inhibition of purified citrate synthase from Crithidia fasciculata, which condenses acetyl-CoA with oxaloacetate, has been reported (26) . Larger inhibition of the .in vivo enzyme cannot, however, be excluded. Inhibition ofpyruvate oxidation by NH4+ in liver mitochondria (Maddaiah VT, and Miller PS, unpublished observations) supports this conclusion. In any event, the effect of NH4+ could be compounded because the accumulated fatty acyl-CoA derivatives may inhibit carbamylphosphate synthetase (27) to cause a further rise of blood NH4' level. All these results suggest that NH4+ may impede the utilization of acetyl-CoA and decrease energy production in the tricarboxylic acid cycle. Therefore, severe hyper- ammonemia may lead to some of the pathophysiology seen in patients with enzyme defects of the urea cycle.
Salicylate exerted inhibitory as well as activation effects at a number of steps in the pathway of palmitate utilization in mitochondrial ATP production (Fig. 5) . Generally, oxidation to ASP + COz was inhibited, whereas oxidation to C02 was activated. Such a dual effect is analogous to the actions reported for uncouplers of mitochondrial oxidative phosphorylation (25) . Inhibition was relieved by carnitine either completely or partially, depending upon the concentration of salicylate. In view of the well-established role of carnitine (19) , one of the inhibitory sites appears to be the transport of palmitoylcarnitine into mitochondria (Fig. 5) . As to the mechanism of carnitine effect, the possibility that it may increase salicylate detoxification by esterification exists. However, this appears unlikely because the activating effect of salicylate on COz formation was further increased by carnitine. Inhibition of transport would be in addition to that reported for the initial step of fatty acid activation by acyl-CoA ligases (6) . Large decreases in the formation of ASP + COz in the presence of carnitine but at high concentrations of salicylate suggests that other step(s) in the P-oxidation pathway may also be inhibited.
The other salicylate effect is uncoupling of oxidative phosphorylation, which is supported by the observations that salicylate decreased protonmotive force and transmembrane potential in isolated liver mitochondria (28) . Similar to proton ionophores, salicylate, because of its proton-carrying capacity, can effectively dissipate proton gradient across the inner mitochondrial membrane to by-pass ATP synthesis (Fig. 5) . Salicylate can thus increase respiration but decrease ATP synthesis. At low or moderate concentrations, it increases respiration by uncoupling with no or slight inhibition of palmitic acid oxidation to ASP + CO?.
However, at high concentrations of salicylate, severe inhibition of the (?-oxidation pathway as well as swelling (7) may set in, leading to mitochondrial deterioration. The observation of strong inhibitory effect on palmitate oxidation by a combination of NH4+ and moderate concentration (0.75 mM) of salicylate and the partial ameliorating effect by carnitine is of clinical relevance.
